Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Th17 cells are involved in the pathogenesis of many autoimmune diseases, but it is not clear whether they play a pathogenic role in type 1 diabetes. Here we investigated whether mouse Th17 cells with specificity for an islet antigen can induce diabetes upon transfer into NOD/SCID recipient mice. Induction of diabetes in NOD/SCID mice via adoptive transfer of Th1 cells from BDC2.5 transgenic mice was prevented by treatment of the recipient mice with a neutralizing IFN-γ-specific antibody. This result suggested a major role of Th1 cells in the induction of disease in this model of type 1 diabetes. Nevertheless, transfer of highly purified Th17 cells from BDC2.5 transgenic mice caused diabetes in NOD/SCID recipients with similar rates of onset as in transfer of Th1 cells. However, treatment with neutralizing IL-17-specific antibodies did not prevent disease. Instead, the transferred Th17 cells, completely devoid of IFN-γ at the time of transfer, rapidly converted to secrete IFN-γ in the NOD/SCID recipients. Purified Th17 cells also upregulated Tbet and secreted IFN-γ upon exposure to IL-12 in vitro and in vivo in NOD/SCID recipients. These results indicate substantial plasticity of Th17 commitment toward a Th1-like profile.

[1]  Christoph Wilhelm,et al.  Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.

[2]  Hyun-Dong Chang,et al.  Th memory for interleukin‐17 expression is stable in vivo , 2008, European journal of immunology.

[3]  Chen Dong,et al.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. , 2008, Immunity.

[4]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[5]  M. Altfeld,et al.  Rapid ex vivo isolation and long-term culture of human Th17 cells. , 2008, Journal of immunological methods.

[6]  Y. Iwakura,et al.  Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.

[7]  R. Zinkernagel,et al.  Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors , 2008, The Journal of experimental medicine.

[8]  Hyun-Hee Lee,et al.  Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production , 2008, The Journal of experimental medicine.

[9]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[10]  J. Bluestone,et al.  Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment , 2007, Proceedings of the National Academy of Sciences.

[11]  M. Kurrer,et al.  Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis , 2006, European journal of immunology.

[12]  C. Uyttenhove,et al.  Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis , 2006, European journal of immunology.

[13]  G. Jennings,et al.  Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis , 2006, European journal of immunology.

[14]  R. J. Hocking,et al.  Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease , 2006, Nature Immunology.

[15]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[16]  D. G. Zisoulis,et al.  T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. , 2006, Blood.

[17]  R. Flavell,et al.  Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .

[18]  A. Cooke,et al.  Salmonella typhimurium Infection in Nonobese Diabetic Mice Generates Immunomodulatory Dendritic Cells Able to Prevent Type 1 Diabetes1 , 2006, The Journal of Immunology.

[19]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[20]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[21]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[22]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[23]  D. Altmann,et al.  Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. , 2005, International immunology.

[24]  Meng Chen,et al.  Autoimmune diabetes is blocked in Stat4-deficient mice. , 2004, Journal of autoimmunity.

[25]  R. Maki,et al.  Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice , 2003, The Journal of Immunology.

[26]  C. Janeway,et al.  Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. , 2002, Journal of autoimmunity.

[27]  L Adorini,et al.  Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains , 2002, Genes and Immunity.

[28]  A. Cooke,et al.  Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes1 , 2001, The Journal of Immunology.

[29]  P. Rothman,et al.  Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. , 2000, Diabetes.

[30]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[31]  A. Tevaarwerk,et al.  Protection of Nonobese Diabetic Mice from Diabetes by Gene(s) Closely Linked to IFN-γ Receptor Loci1 , 2000, The Journal of Immunology.

[32]  J. Miyazaki,et al.  Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. , 1998, The Journal of clinical investigation.

[33]  C. Benoist,et al.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Sarvetnick,et al.  Mechanism underlying counterregulation of autoimmune diabetes by IL-4. , 1997, Immunity.

[35]  F. Nicoletti,et al.  The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. , 1996, Endocrinology.

[36]  Xiaojian Huang,et al.  Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.

[37]  K. Murphy,et al.  Reversibility of T helper 1 and 2 populations is lost after long-term stimulation , 1996, The Journal of experimental medicine.

[38]  A. Cooke,et al.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. , 1995, The Journal of clinical investigation.

[39]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[40]  L. Adorini,et al.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice , 1995, The Journal of experimental medicine.

[41]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[42]  S. Gordon,et al.  Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages , 1990, Nature.

[43]  R. Flavell,et al.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. , 2006, Immunity.

[44]  R. Maki,et al.  Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. , 2003, Journal of immunology.

[45]  N. Dybdal,et al.  Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. , 1996, Diabetes.